Globus Medical (NYSE: GMED) reported Q1 EPS of $0.42, $0.05 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $230.5 million versus the consensus estimate of $234.17 million.

GUIDANCE:

Globus Medical sees FY2022 EPS of $2.10, versus the consensus of $2.10. Globus Medical sees FY2022 revenue of $1.03 billion, versus the consensus of $1.03 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.